Multiple myeloma: open trials in Switzerland

13 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Inselspital Universitätsspital Bern, Bern · Kantonsspital St. Gallen, Sankt Gallen
Registry updated 2026-11-03
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Inselspital Bern, Bern · Cantonal Hospital St Gallen, Sankt Gallen
Registry updated 2026-10-29
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Trial Treatment · Phase 3 · Pfizer
Inselspital Bern, Bern · Kantonsspital Winterthur, Winterthur
Registry updated 2026-10-27
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Trial Treatment · Phase 3 · European Myeloma Network B.V.
University Hospital Basel, Basel · Inselspital, Bern · Kantonsspital St. Gallen, Sankt Gallen
Registry updated 2026-10-07
NCT07705074
FAPI PET Imaging - An Exploratory Study
Trial Treatment · Phase 1/2 · Martin Huellner
Kantonsspital Baden, Baden · Hôpitaux Universitaires de Genève (HUG), Geneva · Clinique de Genolier, Genolier · Luzerner Kantonsspital, Lucerne · Department for Nuclear Medicine, University Hospital Zurich, Zurich
Registry updated 2026-07-15
NCT07624760
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
Trial Treatment · University of Zurich
University Hospital Zurich, Zurich
Registry updated 2026-06-03
NCT06932562
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Trial Treatment · Phase 3 · European Myeloma Network B.V.
Universitaetsspital Basel - Zentrum fur Hamato-Onkologie, Basel · Kantonsspital St. Gallen, Sankt Gallen
Registry updated 2026-03-25
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
University Hospital Basel, Basel · University Hospital Bern / Inselspital, Bern · Universitaetsspital Zuerich - Haematology, Zurich
Registry updated 2026-03-24
NCT06357754
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Research · Bristol-Myers Squibb
Kantonsspital Aarau, Aarau
Registry updated 2026-01-22
NCT07309497
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
Research · University of Zurich
Inselspital Bern, Bern · Universitätsspital Zürich, Zurich
Registry updated 2025-12-30
NCT06237803
European Myeloma Network (EMN) Sample Project
Research · European Myeloma Network B.V.
CHUV, Lausanne · HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen
Registry updated 2025-12-03
NCT05636787
Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients
Trial Treatment · Phase 2 · Insel Gruppe AG, University Hospital Bern
Departement of Medical Oncology, University Hospital Berne, Bern
Registry updated 2024-07-08
NCT06430736
PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)
Trial Treatment · Phase 2 · Insel Gruppe AG, University Hospital Bern
Insel Gruppe AG, Bern
Registry updated 2024-07-08

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error